Trials / Completed
CompletedNCT00828412
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
A Randomized, Investigator-Blind, Six-Week, Parallel Group, Multicenter Pilot Study to Compare the Safety and Efficacy of EpiCeram Skin Barrier Emulsion and Desonide Cream 0.05% in the Twice Daily Treatment of Pediatric Subjects With Moderate Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Promius Pharma, LLC · Industry
- Sex
- All
- Age
- 3 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EpiCeram Skin Barrier Emulsion | topical cream, twice daily, 6 weeks |
| DRUG | Desonide Cream 0.05% | topical cream, twice daily, 6 weeks |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2009-01-26
- Last updated
- 2017-01-30
- Results posted
- 2013-12-09
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00828412. Inclusion in this directory is not an endorsement.